Faster and Better Rehabilitation to Improve Neurological Patients’ Quality of Life
Few patients are currently using Liftya and benefit from it. The company is filing for CE mark regs documentation and planning to get approval by Q2 2024. A new technology development (Gen 2) for fast acquisition of the anatomy and quick production will be carried out with a bioengineering R&D consulting partner. The advanced kinematics analysis will be done in collaboration with Politecnico of Torino and Aalborg Universities, both renowned bioengineering departments, starting in November 2023. We will start experimental patients’ trials at both neuro and ortho rehabilitation centres in Q2 2024.